[1]韩婷婷,王 虹,吴美美,等.N-proBNP对慢性心衰患者发生肺动脉高压的预测价值[J].医学信息,2019,32(05):114-116.[doi:10.3969/j.issn.1006-1959.2019.05.035]
　HAN Ting-ting,WANG Hong,WU Mei-mei,et al.Predictive Value of N-proBNP for Pulmonary Hypertension in Patients with Chronic Heart Failure[J].Medical Information,2019,32(05):114-116.[doi:10.3969/j.issn.1006-1959.2019.05.035]
点击复制

N-proBNP对慢性心衰患者发生肺动脉高压的预测价值()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年05期
页码:
114-116
栏目:
临床研究
出版日期:
2019-03-01

文章信息/Info

Title:
Predictive Value of N-proBNP for Pulmonary Hypertension in Patients with Chronic Heart Failure
文章编号:
1006-1959（2019）05-0114-03
作者:
韩婷婷; 王 虹; 吴美美; 杨利娇; 李舒承
（承德医学院附属医院心内科，河北 承德 067000）
Author(s):
HAN Ting-ting; WANG Hong; WU Mei-mei; YANG Li-jiao; LI Shu-cheng
(Department of Cardiology,the Affiliated Hospital of Chengde Medical College,Chengde 067000,Hebei,China)
关键词:
慢性心力衰竭; 肺动脉高压; N末端脑钠肽前体
Keywords:
Chronic heart failure; Pulmonary hypertension; N-terminal pro-brain natriuretic peptide
分类号:
R541.6
DOI:
10.3969/j.issn.1006-1959.2019.05.035
文献标志码:
A
摘要:
目的 探讨N-proBNP对慢性心力衰竭患者合并肺动脉高压的预测价值。方法 选取我院心脏科住院的140例心力衰竭患者，根据是否发生肺动脉高压，分为心衰合并肺动脉高压组110例及心衰未合并肺动脉高压组30例，收集临床资料及实验室指标，分析N-ProBNP水平对心衰发生肺动脉高压预测价值。结果 与未发生肺动脉高压相比，合并肺动脉高压组中N-proBNP、尿酸、总胆红素、心率、心功能分级差异有统计学有意义（P＜0.05）。相关性分析显示，尿酸、总胆红素、心率、红细胞分布宽度、N-proBNP与肺动脉高压之间存在正相关（r=0.237、0.355、0.225、0.259、0.357，P＜0.05），将其进行多元线性回归分析发现，总胆红素及N-proBNP与肺动脉高压独立相关。ROC曲线显示，N-proBNP对心衰合并肺动脉高压有很好的预测价值，曲线下面积为0.678。结论 N-ProBNP对心衰肺动发生脉高压有很好的预测价值。
Abstract:
Objective To investigate the predictive value of N-proBNP in patients with chronic heart failure complicated with pulmonary hypertension. Methods A total of 140 patients with heart failure admitted to our department of cardiology were enrolled. According to whether pulmonary hypertension occurred, 110 patients with heart failure and pulmonary hypertension group and 30 patients with heart failure without pulmonary hypertension were collected. Clinical data and laboratory indicators were collected and analyzed. The predictive value of N-ProBNP levels for pulmonary hypertension in patients with heart failure. Results Compared with no pulmonary hypertension, the difference of N-proBNP, uric acid, total bilirubin, heart rate and cardiac function between the patients with pulmonary hypertension was statistically significant (P<0.05). Correlation analysis showed that there was a positive correlation between uric acid, total bilirubin, heart rate, red blood cell distribution width, N-proBNP and pulmonary hypertension (r=0.237, 0.355, 0.225, 0.259, 0.357, P<0.05). Multiple linear regression analysis found that total bilirubin and N-proBNP were independently associated with pulmonary hypertension. The ROC curve showed that N-proBNP has a good predictive value for heart failure combined with pulmonary hypertension, and the area under the curve is 0.678. Conclusion N-ProBNP has a good predictive value for pulmonary hypertension in patients with heart failure.

参考文献/References:


[1]Damy T,Goode KM,Kallvikbacka-Bennett A,et al.Determinants and prognostic value of pulmonary arterial pressure in patients with chronic heart failure[J].European Heart Journal,2010,31(18):2280-2290.
[2]Szwejkowski BR,Elder DHJ,Fiona S,et al.Pulmonary hypertension predicts all-cause mortality in patients with heart failure: a retrospective cohort study[J].European Journal of Heart Failure,2012,14(2):162-167.
[3]Anderssen AK,Wergeland R,Simonsen S,et al.N-terminal pro-B-type natriuretic peptide as an in dictator of disease severity in a heterogeneous group of patients with chromic precapility pulmonary hypertension[J].Am J Cardiol,2006,98(4):525-529.
[4]中华医学会心血管病学分会.中国心力衰竭诊断和治疗指南[J].中华心血管病杂志,2014,42(2):98-122.
[5]孙路路,吕蓉,韦丙奇,等.N末端B型利钠肽原与大内皮素对伴或不伴肺动脉高压心力衰竭的判断价值[J].中国循环杂志,2013,28(6):438-441.
[6]Shen Binru,Zhang YU,Yan Cui,et al.Differences of Plasma NT-proBNP Level in Patients With Left Heart Failure Combining or not Combining Pulmonary Hypertension[J].Chinese Circulation Jourul,2016,31(3):226-228.
[7]张婷,雷红.扩张型心肌病继发肺动脉高压与血尿酸的相关性研究[J].中国循证心血管医学杂志,2017,9(4):460-463.
[8]Ambrosy AP,VaduganathanM,Huffman MD,et,al.Clinicalcourse and predictive value of liver function tests in patienes hospitallzed for worsening heart failure with reducedejection fraction:ananalysis of the EVEREST trial[J].EurJ Heart Fail,2012,149(3):302.

相似文献/References:

[1]周婷婷,万毅新.巨大肺动脉瘤伴重度肺动脉高压1例并文献复习[J].医学信息,2018,31(03):191.[doi:10.3969/j.issn.1006-1959.2018.03.073]
　ZHOU Ting-ting,WAN Yi-xin.Giant Pulmonary Aneurysm with Severe Pulmonary Hypertension:a Case Report and Literature Review[J].Medical Information,2018,31(05):191.[doi:10.3969/j.issn.1006-1959.2018.03.073]
[2]贺明清,刘孝娅.环磷腺苷葡胺治疗慢性心力衰竭临床疗效观察[J].医学信息,2018,31(10):135.[doi:10.3969/j.issn.1006-1959.2018.10.045]
　HE Ming-qing,LIU Xiao-ya.Clinical Efficacy of Cyclic Adenosine Glucosamine in the Treatment of Chronic Heart Failure[J].Medical Information,2018,31(05):135.[doi:10.3969/j.issn.1006-1959.2018.10.045]
[3]李祥敏.多普勒彩超在慢性心力衰竭患者中的诊断特点分析[J].医学信息,2022,35(11):144.[doi:10.3969/j.issn.1006-1959.2022.11.038]
　LI Xiang-min.Analysis of Diagnostic Characteristics of Doppler Ultrasound in Patients with Chronic Heart Failure[J].Medical Information,2022,35(05):144.[doi:10.3969/j.issn.1006-1959.2022.11.038]
[4]付 敏.基于医院的延续性护理对慢性心力衰竭患者自我护理能力及生活质量的影响[J].医学信息,2022,35(11):187.[doi:10.3969/j.issn.1006-1959.2022.11.050]
　FU Min.Effect of Hospital-based Continuous Nursing on Self-care Ability and Quality of Life in Patients with Chronic Heart Failure[J].Medical Information,2022,35(05):187.[doi:10.3969/j.issn.1006-1959.2022.11.050]
[5]李鹏飞,何荣华,王琼涛,等.单胺氧化酶对老年心力衰竭患者临床应用价值[J].医学信息,2018,31(17):78.[doi:10.3969/j.issn.1006-1959.2018.17.023]
　LI Peng-fei,HE Rong-hua,WANG Qiong-tao,et al.Clinical Value of Monoamine Oxidase in Elderly Patients with Heart Failure[J].Medical Information,2018,31(05):78.[doi:10.3969/j.issn.1006-1959.2018.17.023]
[6]马 麟,廖宝兰,钟周华.超声心动图诊断老年冠心病患者肺动脉高压的临床价值分析[J].医学信息,2018,31(21):173.[doi:10.3969/j.issn.1006-1959.2018.21.051]
　MA Lin,LIAO Bao-lan,ZHONG Zhou-hua.Clinical Value of Echocardiography in Diagnosis of Pulmonary Hypertension in Elderly Patients with Coronary Heart Disease[J].Medical Information,2018,31(05):173.[doi:10.3969/j.issn.1006-1959.2018.21.051]
[7]曹 云,李树茂,裘 冬,等.益气温阳中药治疗慢性舒张性心力衰竭的疗效观察[J].医学信息,2019,32(01):162.[doi:10.3969/j.issn.1006-1959.2019.01.051]
　CAO Yun,LI Shu-mao,QIU Dong,et al.Therapeutic Effect of Yiqiwenyang Chinese Medicine on Chronic Diastolic Heart Failure[J].Medical Information,2019,32(05):162.[doi:10.3969/j.issn.1006-1959.2019.01.051]
[8]李 月,胡 雅,曹春乐,等.慢性心力衰竭患者健康心理控制源与自我管理的相关性研究[J].医学信息,2019,32(05):133.[doi:10.3969/j.issn.1006-1959.2019.05.042]
　LI Yue,HU Ya,CAO Chun-le,et al.Correlation between Health Psychological Control Sources and Self-management in Patients with Chronic Heart Failure[J].Medical Information,2019,32(05):133.[doi:10.3969/j.issn.1006-1959.2019.05.042]
[9]卞丛燕,徐卫亭,古小松.肺动脉高压的血栓栓塞的机制[J].医学信息,2019,32(09):25.[doi:10.3969/j.issn.1006-1959.2019.09.009]
　BIAN Cong-yan,XU Wei-ting,GU Xiao-song.Mechanism of Thromboembolism in Pulmonary Arterial Hypertension[J].Medical Information,2019,32(05):25.[doi:10.3969/j.issn.1006-1959.2019.09.009]
[10]张文波,杨玉雯.希氏束起搏在慢性心力衰竭患者中的应用[J].医学信息,2019,32(10):41.[doi:10.3969/j.issn.1006-1959.2019.10.015]
　ZHANG Wen-bo,YANG Yu-wen.Application of His Bundle Pacing in Patients with Chronic Heart Failure[J].Medical Information,2019,32(05):41.[doi:10.3969/j.issn.1006-1959.2019.10.015]

更新日期/Last Update: 2019-03-01